Read + Share
Amedeo Smart
Independent Medical Education
Chang L, Kang Y, Zhu M, Liu J, et al. Efficacy and safety of immune checkpoint inhibitors combined with TKIs for recurrent or metastatic cervical cancer with PIK3CA mutation. PLoS One 2026;21:e0350571.PMID: 42809552
Email
LinkedIn
Privacy Policy